Respiratory Care Devices Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 The global respiratory care devices market size is expected to register a significant growth at 10.1% CAGR during the forecast period (2018–2023).

The respiratory care devices are used for treatment, assessment, diagnosis, and care of patients suffering from cardiopulmonary devices. Respiratory care devices are used in the treatment of lung diseases such as chronic bronchitis, tuberculosis, acute and chronic pulmonary diseases, asthma, and others. With the growing age, the function of lungs starts to decline and hence the respiratory system undergoes various physiological, functional and immunological changes. The market growth is due to the rising incidences of chronic pulmonary diseases, asthma, and others. These devices can be used in hospitals and in-home care settings as they have developed from stationary to portable ones.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6517  

Factors such as the increasing frequency of respiratory diseases, increasing geriatric population, urbanization, and its adverse effects, and changes in the environment and lifestyle boosts the growth of the market. The growing demand for point-of-care diagnostic devices in developing regions is anticipated to provide new opportunities for players in the respiratory care devices market. The lack of awareness about respiratory problems, intense competition, and the cost associated with the device and the respiratory surgery hamper the growth of the market.

Segmentation

The global respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users. On the basis of therapeutic devices, the market has been classified as pap devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers. On the basis of diagnostic devices, the market has been classified as spirometers, polysomnography (PSG) devices, peak flow meters, and other diagnostic devices. On the basis of accessories and consumables, the market has been classified as disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables and accessories. On the basis of application, the market has been classified as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other diseases. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory care, home care, and others.

Regional Analysis

The Americas is projected to lead the respiratory care devices market during the forecast period. Increasing healthcare awareness, advancement in technology, and medical tourism are some other factors that boost the growth of the market. According to the statistics of Life and Breath, on an average 72 Canadians were diagnosed with lung cancer daily and 56 Canadians died from lung cancer on a daily basis in 2014.

The European market is expected to hold the second largest market share. According to the statistics of the British Lung Foundation in the year 2014, around 10,000 people in the UK are newly diagnosed with a respiratory disease every week. According to the statistics of the British Lung Foundation, lung diseases are accountable for more than 7,00,000 hospital admissions and over 6 million inpatient bed-days in the UK each year.

Asia-Pacific is projected to be the fastest growing region for the global respiratory care devices market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. According to the Asia-Pacific Lung Cancer Conference (APLCC), 90% of the lung cancer cases are due to the rise in the consumption of tobacco.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players

Some of the key players in the global respiratory care devices market are Philips Healthcare (The Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/respiratory-care-devices-market-6517 

Wearable Injectors Market Insights Analysis 2020-2027

 The global wearable injectors market size is expected to grow significantly over the forecast period. It is estimated that the global wearable injectors market is expected to register a CAGR of ~ 15.2% during the forecast period from 2018 to 2023. Wearable Injectors are medical devices designed to dispense large doses of the drug. Wearable Injectors are user-friendly, convenient and they lessen the need for multiple painful injections.

Numerous factors such as growing demand of convenient methods of drug administration, rising prevalence of chronic diseases such as diabetes, technological advancements and design development in wearable injectors are expected to drive the growth of the market. For instance, in July 2016, Amgen received US Food and Drug Administration (FDA) approval for its on-body wearable injector, Repatha (evolocumab) Pushtronex system, a human monoclonal antibody injector.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6491 

Moreover, favorable healthcare investments by government and the rising demand for minimally invasive devices boosts the growth of the market. However, stringent government regulation for product approval and the growing preference for traditional methods of drug delivery may hamper the market growth during the assessment period.

Regional Analysis

The market in the Americas is expected to dominate the global wearable injectors Market during the forecast period owing to the presence of well-established healthcare infrastructure and advanced technologies to administer drugs for the treatment of chronic diseases like diabetes. According to the National Diabetes Statistics Report 2017, an estimated 30.3 million people of all ages had diabetes in the US in 2015. The European market is expected to be the second-largest due to the growing medical devices industry in France, Germany & the UK and the rising opportunities for the market players. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to favorable government initiatives for the medical devices industry. The market in the Middle East & Africa is likely to account for the smallest share of the global wearable injectors market. The market growth in this region can be attributed to the rising research and development activities in the region.

Segmentation

The global wearable injectors market has been segmented into type, usage, mechanism of injection, therapeutic area, and end user.

The market, on the basis of type, has been segmented into on-body wearable injectors, off-body wearable injectors, and hand-held wearable injectors.

The market, by usage, has been segmented into disposable and semi-reusable.

The market, by mechanism of injection, has been segmented into spring based, motor driven, rotary pump, expanding battery, pressurized gas, and collapsible reservoir.

The market, by therapeutic area, has been segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and others.

The market, by end-user, has been segmented into hospitals, clinics, home care, ambulatory surgery centers, and others.

Key Players

Some of the key players in the global wearable injectors market are West Pharmaceutical Services, Inc., Valeritas, Inc., Eli Lilly and Company, YPSOMED, Amgen Inc., Becton, Dickinson and Company (BD), CeQur SA, SteadyMed Therapeutics, Inc., BioSpace, Enable Injections, and Sensile Medical AG.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/wearable-injectors-market-6491 

Research report explores the Surgical Stapler Market for the forecast period, 2020-2027

 The Global Surgical Stapler Market size  is expected to grow during the forecast period (2018 to 2023) at a CAGR approx. 7.2 %.

A surgical stapler is a complex mechanical medical device that has been present in the market for years and is mature in technology. Surgical staplers are used in various surgeries such as gastrointestinal, gynecologic, thoracic, and many other surgeries to remove the part of organ and tissues. This surgical stapler reduces the time of surgical procedure. The global surgical stapler market is increasing due to increasing surgical procedures, the introduction of technologically advanced surgical staplers, and growing number of bariatric and other weight loss surgeries. However, due to increasing aesthetic surgeries, breast surgeries, surgical technology, and pediatric surgical procedures, the surgical stapler market size is expected to grow in the future.  

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6382 

However, the high cost of treatment, misuse of funding, and lack of awareness are some of the factors which are expected to hamper the growth of the market during the forecast period.

Regional Analysis

North America will dominate the surgical stapler market during the forecast period. Technological advancements, growing geriatric population, and rising number of surgical procedures are likely to drive the surgical stapler market during the forecast period. North America and Europe are expected to hold a major share of around 70% of the surgical stapler market during the forecast period. The European market is expected to be the second-largest surgical stapler market. The market growth in this region can be attributed to the increasing awareness and adoption of advanced surgical technology. Asia-Pacific is expected to be the fastest-growing surgical stapler market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving strong competition to the global surgical stapler market by producing cost-effective treatments that are high in demand in local as well as global markets. The market in the Middle East and Africa is expected to account for the smallest share in the global surgical stapler market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Segmentation

The global surgical stapler market is segmented into types, product, application, and end-users. Based on types the surgical stapler market is segmented into disposable surgical staplers and reusable surgical staplers. On the basis of product, the market is segmented into manual surgical staplers and powered surgical staplers. Based on application, the surgical stapler market is segmented into abdominal and pelvic surgery, general surgery, cardiac and thoracic surgery, orthopedic surgery, and other surgical applications. Based on end-user the market is segmented into hospitals, ambulatory surgical centers (ASCs), and clinics.

Key Players

Some of the key players in the global surgical stapler market are  Ethicon. US, LLC., Cardica Inc, Smith and Nephew Plc, CONMED Corporation, Purple Surgical Inc., Welfare Medical Ltd, Reach Surgical, Grena Ltd, B.Braun Melsungen AG, Frankenman International Limited, Zimmer Biomet, Stryker, Meril Life Sciences Pvt. Ltd., Touchstone International Medical Science Co. Ltd, Medtronic.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-stapler-market-6382 

Global Artificial Neural Network Market size and forecast, 2020-2027

 The global artificial neural network market size  is expected to grow significantly over the forecast period. It is estimated that the global artificial neural network market is expected to grow significantly during the forecast period from 2018 to 2023.

An artificial neuron network is a computational model which resembles the function and structure of the human brain’s neuron system. The emergence of artificial intelligence and increasing adoption of the artificial neural network in the healthcare sector are the major drivers for the global artificial neural market. Factors such as the increasing healthcare expenditure, growing number of hospitalizations, and increasing prevalence of chronic diseases contribute to the growth of the market. Moreover, artificial neural networks provide significant benefits in medical research which is expected to fuel the market growth during the forecast period. Furthermore, owing to the growing adoption of artificial neuron network, many companies are engaged in developing artificial neuron network-based software. For instance, MAQ software by Microsoft implements an Artificial Neural Network (ANN) to learn from the historical data and predict the future values.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6287 

Despite the drivers, slow digitization across emerging economies and reluctance among healthcare professionals to adopt artificial intelligence-based technologies are likely to hamper the growth of the market during the assessment period.

Regional Analysis

The market in the Americas is expected to dominate the global artificial neural network market during the forecast period owing to the well-established healthcare sector, the presence of a large number of companies such as Microsoft Corporation, Intel Corporation, and Google Inc. engaged in the development of neural network technologies, and growing adoption of artificial intelligence in the healthcare sector. The European market is expected to be the second-largest market due to the increasing preference for artificial intelligence among healthcare providers, growing healthcare expenditure, and rising prevalence of chronic diseases. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the least market share of the global artificial neural network market. The market growth in this region can be attributed to growing technological implementations and increasing healthcare expenditures.

Segmentation

The global artificial neural network market has been segmented into type, component, and application.

The market, on the basis of type, has been segmented into feedback artificial neural network, feedforward artificial neural network, and others.

The market, by component, has been segmented into software, services, and platform.

The global artificial neural network market, by application, has been segmented into clinical diagnosis and prognostics, image analysis and interpretation, bioelectric signal analysis and interpretation, drug development, and others.

Global Artificial Neural Network Key Players

Some of the prominent players in the global artificial neural network market are Starmind International AG, Neural Technologies Limited, SwiftKey,  Afiniti, Ward Systems Group, Inc., SAP SE, NeuroDimension, Inc., Alyuda Research, LLC., Google Inc., Neuralware, Qualcomm Technologies, Inc., Intel Corporation, Microsoft Corporation, IBM Corporation, and Oracle Corporation.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/artificial-neural-network-market-6287 

Forensic Swab Market – Insights on Upcoming Trends 2027

 The Global Forensic Swab Market is expected to register 5.8% CAGR and is anticipated to reach USD 49.09 Million by 2023. Forensic swabs are extensively used by forensic scientists and crime scene investigators for collecting a wide range of evidence-samples such as blood, saliva, and DNA. These samples are analyzed in the laboratory for desired results. Gathering biological samples for successive DNA analysis is one of the major applications for forensic swabs. Rising criminal activities, increasing adoption of DNA forensics, growing forensic biotechnology sector, and favorable government support are some of the major factors driving the market growth during the forecast period. However, factors such as the high price of DNA free forensic swabs and irregular supply of new products in the market are projected to restrain the market growth. However, the growing rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advancements are expected to boost the market growth.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6929

Market Dynamics

The past few years, there has been an increase in criminal activities and reported crimes has increased. According to crime statistics published by the Federal Bureau of Investigation, approximately 17,250 murders were estimated to be reported within the US in 2016. The government support for forensics-related activities is one of the major factors driving the global forensic swab market. The judicial framework of various countries has realized the importance of forensics. Currently, forensics is being utilized as toxicology forensics, DNA forensics, and others for investigating criminal offenses. According to a report on forensic science published by the National Criminal Justice Reference Service, the National Institute of Justice received a funding of USD 125 million through the Department of Justice Appropriations Act in 2017 for boosting DNA and other related forensic programs and activities and sexual assault forensic exams.

Segmentation

The global forensic swab market has been segmented into type, type of swab shaft, and end user.

Based on type, the global market has been segmented into foam, flocked, and cotton.

Based on type of swab shaft, the global market has been segmented into wood-stick shaft, polystyrene shaft.

Based on end user, the global market has been divided into forensic science laboratories and hospitals.

Key Players

The prominent players in the global forensic swab market are Becton, Dickinson and Company Thermo Fisher Scientific Inc., Merck KGaA, Copan Italia S.p.A., MWE, SARSTEDT AG & Co. KG, Luna, Puritan Medical Products, Sirchie, and MEDTECH Forensics.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/forensic-swab-market-6929

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Orthokeratology Lens Market Forecast to 2027 – Driven by Industry Major Players, Dynamics, Future Opportunities, Revenue, Growth

 Global Orthokeratology Lens Market is expected to register a CAGR of 7.4% to reach USD 3,857.8 Million till 2025.

Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. It is a non-surgical method used to correct refractive errors by reshaping the curvature of the cornea to improve object visibility. This procedure is a temporary treatment method used for the correction of myopia, hypermetropia, and other eye-related problems.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/8218

The growing prevalence of refractive errors across the globe, advancements in the field of ophthalmology over the past couple of decades and low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is expected to enhance the market growth. However, the availability of alternative treatment methods and risk associated with orthokeratology are projected to curb the growth of the market.

Market Dynamics

A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods. Myopia is reported as the most common disorder affecting a large number of populations worldwide. The World Health Organization 2018 fact sheet estimated that approximately 1.3 billion people were living with some form of vision impairment. It also reported that 188.5 million patients have a mild vision impairment, 217 million people have moderate to severe vision impairment, and 36 million people are blind, globally. Such a vast population suffering from eye problems boosts market growth during the forecast period.

Segmentation

The global orthokeratology lens market, by material, has been segmented into silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. On the basis of application, the global orthokeratology lens market has been segmented into myopia and hyperopia. Based on end user, the market has been segmented into hospitals and ophthalmic clinic.

Regional Analysis

The global orthokeratology lens market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global orthokeratology lens market. The growth of the Americas can be attributed to its rising geriatric population and increasing ophthalmological disorders, causing an increased need for diagnosis and therapeutics.

Asia-Pacific is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are the rising patient population of people with eye disorders, availability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the presence of good healthcare infrastructure. According to the Asian Development Bank, the elderly population in Asia is projected to reach nearly 923 million by 2050.

Europe is estimated to be growing at the fastest pace in the global market due to the increasing cases of eye disorders and increasing government initiatives are driving the growth of the market. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired.

The orthokeratology lens market in the Middle East & Africa is expected to exhibit the least growth in the global orthokeratology lens market due to factors such as limited access to healthcare affordability issues.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orthokeratology-lens-market-8218

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hydrocephalus Market: Information, Figures and Analytical Insights 2020-2027

 The Global Hydrocephalus Market is growing at a healthy pace and is expected to be USD 1,348.00 million in 2017, at a CAGR of 4.4% during the forecast period 2018-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1719

Hydrocephalus is a condition that characterized by buildup of cerebrospinal fluid (CSF) in the brain cavities (ventricles). The ventricles expand as a result of fluid accumulation, causing an abnormal increase in brain size. In normal conditions, the cerebrospinal fluid usually flows through the cavities of the brain and spinal column, but in hydrocephalus, the excessive CSF accumulation causes damage to the brain tissues, leading to a number of brain impairments. This condition can occur in any age, but it is more prevalent in infants and older adults. The increasing prevalence of hydrocephalus is directly responsible for the market growth. The major cause for this condition in children is found to be malnourishment of the fetus. this condition is mostly genetic however, it can also manifest in adults and is known as acquired hydrocephalus.

Shunting is a primary line of treatment for hydrocephalus. Shunting creates a bypass for the accumulated fluid to flow to other parts of the body. The increasing prevalence of traumatic brain injuries due to accidents and shifting patient preference towards minimally invasive surgeries in geriatric population are considered as the key factors that are projected to encourage the growth of the global hydrocephalus market in the coming years. In addition to this, the growing disposable income among consumers and the rapid development in the healthcare infrastructure are further predicted to enhance the growth of the overall market in the next few years.

Market Dynamics

The market for hydrocephalus is not very well developed due to lack of attention paid to the treatment of the disease. Following the development of shunts for draining the accumulated cerebrospinal fluid and scans to diagnose this condition, there have been improvements in terms of treatments to provide short-term relief to patients. However, there are efforts to develop treatments to address the disease at initial stages and this has ensured a positive growth trend for the market.

Further, Posttraumatic hydrocephalus (PTH) is a recurrent and serious complication that follows a traumatic brain injury (TBI). The prevalence of this condition varies greatly based on different criteria for its diagnosis. It can be caused by the blockage of normal cerebrospinal fluid (CSF) flow, overproduction of CSF, or insufficient absorption that result in excessive accumulation of CSF around the brain

The use of ICP devices is for measuring the fluid pressure within the brain which may be caused by trauma or other conditions. ICP monitoring has a significant importance in diagnostic and post-operative procedures with cranial injury as seen in cases of stroke, hydrocephalus, and trauma. According to the estimate of the Centers for Disease Control and Prevention (CDC) in 2017, more than 1.75 million traumatic brain injuries occur in North America, annually and these monitoring devices enable surgeons to save lives of patients with timely intervention and treatment. The increasing accidental cases causing traumatic brain injuries are going to act as drivers for the hydrocephalus market.

Segmentation

The global Hydrocephalus market is segmented on the basis of type, diagnostic, treatment, end user. On the basis the type, the market is segmented into congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, ex-vacuo hydrocephalus. on the basis of the diagnostic, the market is segmented into CT scan – head, MRI, head ultrasound. on the basis of treatment, it is segmented into surgery – shunt insertion, ventriculostomy, medication. on the basis of end user, it is segmented into hospitals & clinics, diagnostic centres, academic institutions and research organizations

Regional Analysis

The global market for hydrocephalus is segmented on the basis of regions into Americas, Europe, Asia Pacific, and Middle East & Africa.

The Americas held the largest share of the global hydrocephalus market owing to the rising prevalence of hydrocephalus, the presence of a well-developed healthcare sector, and the major market players. The continuous increase in the number of Americans affected from hydrocephalus coupled with ongoing research in neuroscience aid to the market growth. On a regional basis, the Americas is divided into North America and South America. North America is estimated to lead due to the presence of developed economies such as the US and Canada within the region. South America, however, is estimated to have the faster growth.

Europe stands second in the global market due to the constant evaluation of various techniques by neurosurgeons for the improvement of hydrocephalus management, is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs. The child population, aging in between 0 and 14 years, is estimated to increase from 17.6% of the total population in 2013 to 18.4% of the total population by 2020. This provides favorable background for market growth in Europe.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hydrocephalus-market-1719

About US:

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com